伝染性軟属腫に対する「ヨクイニンエキス散」の臨床効果  placeboを対照とした多施設二重盲検法による比較試験

書誌事項

タイトル別名
  • Therapeutic effect of coix seed (Yokuinin) extract powder on molluscum contagiosum - Well-controlled double blind trials by multi-institutes compared with placebo.
  • Well-Controlled Double Blind Trials by Multi-Institutes Compared with Placebo
  • placeboを対照とした多施設二重盲検法による比較試験
公開日
1987
DOI
  • 10.11340/skinresearch1959.29.762
公開者
日本皮膚科学会大阪地方会

この論文をさがす

説明

In order to confirm the clinical usefulness of coix seed extract powder on molluscum contagiosum, well-controlled double blind trials by multi-institutes compared with placebo were studied. The trial duration was 12 weeks, and the doses by oral administration were two groups, one was 6 g/day for under 30kg, and another was 12g/day for 30 kg and over.<BR>The effectiveness coix seed extract powder group was remarkable useful and useful in 56/91 (61.5%), and the effectiveness of placebo group was remarkable useful and useful in 56/101 (55.4%). A significant difference was not seen in effectiveness between both groups. However, not effective cases in placebo group were about two times in coix seed extract powder group.In usefulness and being-rate of the papules of molluscum contagiosum after four weeks, coix seed extract powder group was superior to placebo group.<BR>A significant difference in effectiveness was observed in coix seed extract powder group ofmale patients. A distinct effectiveness was observed in coix seed extract powder group with atopic dermatits.<BR>Side effects were observed in two cases of coix seed extract powder group and in one case of placebo group, these were not serious.<BR>As the results, it was concluded that coix seed extract powder was safe and useful on moliuscum contagiosum.

収録刊行物

  • 皮膚

    皮膚 29 (4), 762-773, 1987

    日本皮膚科学会大阪地方会

詳細情報 詳細情報について

  • CRID
    1390282679776150400
  • NII論文ID
    130005059956
  • DOI
    10.11340/skinresearch1959.29.762
  • ISSN
    1884541X
    00181390
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ